639 related articles for article (PubMed ID: 28422306)
21. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
22. Frailty in advanced liver disease.
Laube R; Wang H; Park L; Heyman JK; Vidot H; Majumdar A; Strasser SI; McCaughan GW; Liu K
Liver Int; 2018 Dec; 38(12):2117-2128. PubMed ID: 29935102
[TBL] [Abstract][Full Text] [Related]
23. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
24. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
Molinari M; Renfrew PD; Petrie NM; De Coutere S; Abdolell M
Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
[TBL] [Abstract][Full Text] [Related]
26. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
[TBL] [Abstract][Full Text] [Related]
27. A predictive nomogram incorporating gait speed for all-cause mortality in hospitalized cirrhotics.
Wang X; Feng H; Hui Y; Zhao T; Mao L; Fan X; Cui B; Lin L; Zhang J; Wang B; Yu Q; Zhao X; Sun C
Postgrad Med; 2021 Aug; 133(6):680-687. PubMed ID: 34029498
[TBL] [Abstract][Full Text] [Related]
28. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
[TBL] [Abstract][Full Text] [Related]
29. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
[TBL] [Abstract][Full Text] [Related]
30. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
Tohidinezhad F; Eslami S; Abu-Hanna A; Aliakbarian M
Exp Clin Transplant; 2018 Dec; 16(6):721-729. PubMed ID: 29457445
[TBL] [Abstract][Full Text] [Related]
31. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
[TBL] [Abstract][Full Text] [Related]
32. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
[TBL] [Abstract][Full Text] [Related]
33. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.
Dunn MA; Josbeno DA; Tevar AD; Rachakonda V; Ganesh SR; Schmotzer AR; Kallenborn EA; Behari J; Landsittel DP; DiMartini AF; Delitto A
Am J Gastroenterol; 2016 Dec; 111(12):1768-1775. PubMed ID: 27575708
[TBL] [Abstract][Full Text] [Related]
34. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective.
Cavaggioni G; Poli E; Ferri F; Parlati L; Monaco V; Melcore C; Lattanzi B; Merli M; Mennini G; Melandro F; Rossi M; Ginanni Corradini S
Metab Brain Dis; 2017 Jun; 32(3):923-933. PubMed ID: 28397153
[TBL] [Abstract][Full Text] [Related]
35. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
36. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.
Sinclair M; Poltavskiy E; Dodge JL; Lai JC
World J Gastroenterol; 2017 Feb; 23(5):899-905. PubMed ID: 28223735
[TBL] [Abstract][Full Text] [Related]
37. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease.
Derck JE; Thelen AE; Cron DC; Friedman JF; Gerebics AD; Englesbe MJ; Sonnenday CJ
Transplantation; 2015 Feb; 99(2):340-4. PubMed ID: 25606782
[TBL] [Abstract][Full Text] [Related]
38. Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease.
Lai JC; Volk ML; Strasburg D; Alexander N
Transplantation; 2016 Dec; 100(12):2656-2660. PubMed ID: 27495749
[TBL] [Abstract][Full Text] [Related]
39. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
40. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
Bababekov YJ; Hung YC; Chang DC; Rickert CG; Adler JT; Bethea E; Pomfret EA; Pomposelli JJ; Yeh H
Transplantation; 2020 Feb; 104(2):280-284. PubMed ID: 31335769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
